Dr. Frank Nestle is Global Head of Research and also a Chief Scientific Officer at Sanofi based in Cambridge, Massachusetts. He is responsible for Sanofi's main therapeutic areas of Immunology & Inflammation, Oncology including Immuno-Oncology, Neuroscience, Rare Diseases including Rare Blood Disorders and Genomic Medicine with a mandate to innovate and accelerate first and best in class medicines from discovery to clinical proof-of-concept. He previously worked at King’s College London (United Kingdom), where he keeps a professorial affiliation. At King’s, Frank led research and early development projects and teams in the area of Dermatology and Immunology. In addition, he held a number of executive and non-executive roles in hospitals and academia within the UK, in particular at the Biomedical Research Center. There, he built the Clinical Research Facilities and led the Biomarker and Co-Diagnostics Cluster overseeing ross-disease area precision medicine projects and the translational research platforms including Genomics, Flow Cytometry, Translational Bioinformatics and Bioresource. Frank is the outgoing President of the Federation of Clinical Immunology Societies (FOCIS), and also a Fellow of the Academy of Medical Sciences and a Senior Investigator Emeritus at the National Institute for Health Research (NIHR). He has authored over 200 scientific articles and has received several awards and honors, including the Alfred Marchionini Research Award at the 20th World Congress of Dermatology.